ArticleTranslational psychiatry2026
A transcriptomic dimension of neuronal and immune gene programs within the subgenual anterior cingulate cortex in schizophrenia.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Many psychiatric disorders are heritable, but the molecular consequences of genetic risk remain difficult to resolve, in part due to environmental confounds and the complexity of transcriptomic data. This challenge impedes therapeutic development, which relies on integrating genetic and genomic insights. Here, we integrate diagnosis, toxicological exposure, and gene expression to clarify disease-associated transcriptomic patterns in the subgenual anterior cingulate cortex (sgACC), a brain region implicated in affective regulation and psychiatric illness. We applied group regularized canonical correlation analysis (GRCCA)-a multivariate regression method that models interdependent features-to deeply sequenced bulk RNA-seq data from individuals with bipolar disorder (BD; N = 35), major depression (MDD; N = 51), schizophrenia (SCZ; N = 44), and controls (N = 55). Toxicology data from 17 known compounds were included to assess the relative contribution of known environmental exposures. Case-control expression changes were also analyzed using traditional differential gene expression (DGE) analysis to compare biological interpretability across methods. Gene set enrichment analyses evaluated enrichments for neuropsychiatric risk genes, gene ontology pathways, and cell type markers. GRCCA identified a latent variable significantly associated with schizophrenia (p
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.